talent15-stocks-header-logotalent15-stocks-header-logotalent15-stocks-header-logotalent15-stocks-header-logo
  • Stock Trading for the Rest of Us
  • About us
  • Forum
    • Log In
    • Register
  • Contact
  • Start Trading
Hello world!
March 29, 2021
Published by admin on February 10, 2021
Categories
  • Wins
Tags

On 2/5 we alerted Ocugen, Inc. (OCGN) at $3.50 entry. 3 day average exit of $18.00 for a 414% gain. 

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Share
0
admin
admin

Related posts

July 27, 2021

Kintara Therapeutics, Inc. (KTRA)


Read more
June 25, 2021

Cerecor, Inc. (CERC)


Read more

Leave a Reply Cancel reply

You must be logged in to post a comment.

talent15-stocks-header-logo

Follow us

Connect with us


P.O. Box 121
Kannapolis, NC 28082
United States
info@talentfifteen.com
+1.980.296.1515

Recent Posts

  • Kintara Therapeutics, Inc. (KTRA)
  • Cerecor, Inc. (CERC)
  • Ocugen, Inc. (OCGN)
© 2021 Talent Fifteen | All Rights Reserved